The RDCRN program is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.
-
Research
-
- Funding & Notices
-
Rare Diseases Clinical Research Network (RDCRN)
Watch the New I Am Translational Science Video with Mustafa Sahin
Child neurologist Mustafa Sahin, M.D., Ph.D., shares how advances in translation helped his team provide new treatments to young patients with rare neurodevelopmental disorders.
About the RDCRNLearn more about the RDCRN program and its network of study sites.
RDCRN Funding InformationFind out about funding opportunities, how to apply and how to collaborate.
Current RDCRN ConsortiaDiscover the 20 consortia and their central data management and coordinating center.
Rare Diseases Health InformationAccess information about rare diseases for patients and researchers.
Learn more about the RDCRN program and its network of study sites.
Find out about funding opportunities, how to apply and how to collaborate.
Discover the 20 consortia and their central data management and coordinating center.
Rare Diseases Health Information
Access information about rare diseases for patients and researchers.
Work with Us
Learn about the RDCRN
The RDCRN program is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multi-disciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.
NCATS Programs & Initiatives
- Funding & Notices
-
